New approaches to investigating heterogeneity in complex traits

Journal of Medical Genetics

Volumn 40, Issue 8, 2003, Pages 553-559

  Bomprezzi, R ^a   Kovanen, P E ^b   Martin, R ^c  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; AUTOIMMUNE DISEASE; DISEASE PREDISPOSITION; DNA MICROARRAY; GENETIC HETEROGENEITY; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENETIC TRAIT; HUMAN; MOLECULAR GENETICS; MULTIPLE SCLEROSIS; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 0041826863     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.40.8.553     Document Type: Review

References (96)

1. Strachan T, Read AP. Genes in pedigrees. In: Human molecular genetics. 2nd ed. New York: John Wiley, 1999.
2. Verhoef S, Bakker L, Tempelaars AM, Hesseling-Janssen AL, Mazurczak T, Jozwiok S, Fois A, Bartalini G, Zonnenberg BA, van Essen AJ, Lindhout D, Halley DJ, van den Ouweland AM. High rate of mosaicism in tuberous sclerosis complex. Am J Hum Genet 1999;64:1632-7.
3. Threadgill DW, Hunter KW, Williams RW. Genetic dissection of complex and quantitative traits: from fantasy to reality via a community effort. Mamm Genome. 2002;13:175-8.
4. Roach HD, Davies GJ, Attanoos R, Crane M, Adams H, Phillips S. Asbestos: when the dust settles an imaging review of asbestos-related disease. Radiagraphics 2002;22,special No:S167-84.
5. Murphree AL, Benedict WF. Retinoblastoma: clues to human oncogenesis. Science 1984;223:1028-33.
6. Gould DB, John SW. Anterior segment dysgenesis and the developmental glaucomas are complex traits. Hum Mol Genet 2002;11:1185-93.
7. Bittner M, Meltzer P, Chen Y, Jiang Y, Seftor E, Hendrix M, Radmacher M, Simon R, Yakhini Z, Ben-Dor A, Sampas N, Dougherty E, Wang E, Marincola F, Gooden C, Lueders J, Glatfelter A, Pollock P, Carpten J, Gillanders E, Leja D, Dietrich K, Beaudry C, Berens M, Alberts D, Sondak V, Hayward N, Trent J. Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 2000;406:536-40.
8. Khan J, Wei JS, Ringner M, Saal LH, Ladanyi M, Westermann F, Berthold F, Schwab M, Antonescu CR, Peterson C, Meltzer PS. Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nat Med 2001;7:673-9.
9. John S, Jenkins S. Third international meeting on the genetic epidemiology of complex traits, April 4-6, 2002, Cambridge, UK. Hum Mutat 2002;20:227-9.
10. Compston A, Coles A, Multiple sclerosis. Lancet 2002;359:1221-31.
11. Compston A. The genetic epidemiology of multiple sclerosis. Philos Trans R Soc Land B Biol Sci 1999;354:1623-34.
12. Boomsma D, Busjahn A, Peltonen L. Classical twin studies and beyond. Nat Rev Genet 2002;3:872-82.
13. Solvetti M, Ristori G, Bomprezzi R, Pozzilli P, Leslie RD. Twins: mirrors of the immune system. Immunol Today 2000;21:342-7.
14. MocGregor AJ, Lanchbury J, Rigby AS, Kaprio J, Snieder H. Using twin studies to label disease as genetic or environmental is inappropriate. BMJ 2002;324:1100-1.
15. Mumford CJ, Wood NW, Kellar-Wood H, Thorpe JW, Miller DH, Compston DA. The British Isles survey of multiple sclerosis in twins. Neurology 1994;44:11-15.
16. Sadovnick AD, Armstrong H, Rice GP, Bulman D, Hashimoto L, Paty DW, Hashimoto SA, Warren S, Hader W, Murray TJ, et al. A population-based study of multiple sclerosis in twins: update. Ann Neurol 1993;33:281-5.
17. French Group on Multiple Sclerosis. Multiple sclerosis in 54 twinships: concordance rate is independent of zygosity. French Research Group on Multiple Sclerosis. Ann Neurol. 1992;32:724-7.
18. Ristori et al. manuscript in preparation.
19. Abbadi N, Philippe C, Chery M, Gilgenkrantz H, Tome F, Collin H, Theau D, Recan D, Broux O, Fardeau M, et al. Additional case of female monozygotic twins discordant for the clinical manifestations of Duchenne muscular dystrophy due to opposite X-chromosome inactivation. Am J Med Genet 1994;52:198-206.
20. Costa T, Greer W, Rysiecki G, Buncic JR, Ray PN. Monozygotic twins discordant for Aicardi syndrome. J Med Genet 1997;34:688-91.
21. James WH. Review of the contribution of twin studies in the search for non-genetic causes of multiple sclerosis. Neuroepidemiology 1996;15:132-41.
22. The Transatlantic Multiple Sclerosis Genetics Cooperative. A meta-analysis of genomic screens in multiple sclerosis. The Transatlantic Multiple Sclerosis Genetics Cooperative. Mult Scler 2001;7:3-11.
23. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996;273:1516-17.
24. Allison DB, Schork NJ. Selected methodological issues in meiotic mapping of obesity genes in humans: issues of power and efficiency. Behav Genet 1997;27:401-21.
25. Ewens WJ, Spielman RS. The transmission/disequilibrium test: history, subdivision, and admixture. Am J Hum Genet 1995;57:455-64.
26. Sawcer S, Maranian M, Setakis E, Curwen V, Akesson E, Hensiek A, Coraddu F, Roxburgh R, Sawcer D, Gray J, Deans J, Goodfellow PN, Walker N, Clayton D, Compston A. A whole genome screen for linkage disequilibrium in multiple sclerosis confirms disease associations with regions previously linked to susceptibility. Brain 2002;125:1337-47.
27. Compston A, Sawcer S. Genetic analysis of multiple sclerosis. Curr Neurol Neurosci Rep 2002;2:259-66.
28. Jacobsen M, Schweer D, Ziegler A, Gaber R, Schock S, Schwinzer R, Wonigeit K, Lindert RB, Kantarci O, Schaefer-Klein J, Schipper HI, Oertel WH, Heidenreich F, Weinshenker BG, Sommer N, Hemmer B. A point mutation in PTPRC is associated with the development of multiple sclerosis. Nat Genet 2000;26:495-9.
29. Jacobsen M, Hoffmann S, Cepok S, Stei S, Ziegler A, Sommer N, Hemmer B. A novel mutation in PTPRC interferes with splicing and alters the structure of the human CD45 molecule. Immunogenetics 2002;54:158-63.
30. Barcellos LF, Caillier S, Dragone L, Elder M, Vittinghoff E, Bucher P, Lincoln RR, Pericak-Vance M, Haines JL, Weiss A, Hauser SL, Oksenberg JR. PTPRC (CD45) is not associated with the development of multiple sclerosis in US patients. Nat Genet 2001;29:23-4.
31. Vorechovsky I, Kralovicova J, Tchilian E, Masterman T, Zhang Z, Ferry B, Misbah S, Chapel H, Webster D, Hellgren D, Anvret M, Hillert J, Hammarstrom L, Beverley PC. Does 77C-G in PTPRC modify autoimmune disorders linked to the major histocompatibility locus? Nat Genet 2001;29:22-3.
32. Strachan T, Read AP. Genetic mapping of complex characters. In: Human molecular genetics. 2nd ed. New York: john Wiley, 1999.
33. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K. A comprehensive review of genetic association studies. Genet Med 2002;4:45-61.
34. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papepetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di lorio G, Golbe LI, Nussbaum RL. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997;276:2045-7.
35. Scott WK, Staijich JM, Yamaoka LH, Speer MC, Vance JM, Roses AD, Pericak-Vance MA. Genetic complexity and Parkinson's disease. Science 1997;277:387-8.
36. Tabor HK, Risch NJ, Myers RM. Opinion. Candidate-gene approaches for studying complex genetic traits: practical considerations. Nat Rev Genet 2002;3:391-7.
37. Lander ES, Schork NJ. Genetic dissection of complex traits. Science 1994;265:2037-48.
38. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 2003;33:177-82.
39. Nowotny P, Kwon JM, Goate AM. SNP analysis to dissect human traits. Curr Opin Neurobiol 2001;11:637-41.
40. Collins FS, Brooks LD, Chakravarti A. A DNA polymorphism discovery resource for research on human genetic variation. Genome Res 1998;8:1229-31.
41. Weiss KM, Clark AG. Linkage disequilibrium and the mapping of complex human traits. Trends Genet 2002;18:19-24.
42. Collins A, Lonjou C, Morton NE. Genetic epidemiology of single-nucleotide polymorphisms. Proc Natl Acad Sci USA 1999;96:15173-7.
43. Waterston RH, Lindblad-Toh K, Birney E, Rogers J, Abril JF, Agarwal P, Agarwala R, Ainscough R, Alexandersson M, An P, Antonarakis SE, Attwood J, Baertsch R, Bailey J, Barlow K, Beck S, Berry E, Birren B, Bloom T, Bork P, Botcherby M, Bray N, Brent MR, Brown DG, Brown SD, Bult C, Burton J, Butler J, Campbell RD, Carninci P, Cawley S, Chiaromonte F, Chinwalla AT, Church DM, Clamp M, et al. Initial sequencing and comparative analysis of the mouse genome. Nature 2002;420:520-62.
44. Griffiths AJF, Gelbart WM, Miller JH, Lewontin RC. Genetics begins with variation. In: Modern genetic analysis. New York: W H Freeman, 1999.
45. Passarge E. Dissecting Hirschsprung disease. Nat Genet 2002;31:11-12.
46. Shirakawa T, Enomoto T, Shimazu S, Hopkin JM. The inverse association between tuberculin responses and atopic disorder. Science 1997;275:77-9.
47. Rook GA, Stanford JL. Give us this day our daily germs. Immunol Today 1998;19:113-16.
48. Rook GA. Clean living increases more than just atopic disease. Immunol Today 2000;21:249-50.
49. Fearon DT, Locksley RM. The instructive role of innate immunity in the acquired immune response. Science 1996;272:50-3.
50. Ristori G, Buttinelli C, Pozzilli C, Fieschi C, Salvetti M. Microbe exposure, innate immunity and autoimmunity. Immunol Today 1999;20:54.
51. Hemmer B, Archelos JJ, Hartung HP. New concepts in the immunopathogenesis of multiple sclerosis. Nat Rev Neurosci 2002;3:291-301.
52. Sawcer S, Goodfellow PN, Compston A. The genetic analysis of multiple sclerosis. Trends Genet 1997;13:234-9.
53. Chataway J, Feakes R, Coraddu F, Gray J, Deans J, Fraser M, Robertson N, Broadley S, Jones H, Clayton D, Goodfellow P, Sawcer S, Compston A. The genetics of multiple sclerosis: principles, background and updated results of the United Kingdom systematic genome screen. Brain 1998;121:1869-87.
54. Dyment DA, Sadovnick AD, Ebers GC. Genetics of multiple sclerosis. Hum Mol Genet 1997;6:1693-8.
55. Sawcer S, Jones HB, Feakes R, Gray J, Smaldon N, Chataway J, Robertson N, Clayton D, Goodfellow PN, Compston A. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nat Genet 1996;13:464-8.
56. Coraddu F, Sawcer S, Feakes R, Chataway J, Broadley S, Jones HB, Clayton D, Gray J, Smith S, Taylor C, Goodfellow PN, Compston A. HLA typing in the United Kingdom multiple sclerosis genome screen. Neurogenetics 1998;2:24-33.
57. Hensiek AE, Sawcer SJ, Feakes R, Deans J, Mander A, Akesson E, Roxburgh R, Coraddu F, Smith S, Compston DA. HLA-DR 15 is associated with female sex and younger age at diagnosis in multiple sclerosis. J Neurol Neurosurg Psychiatry 2002;72:184-7.
58. Tubridy N, Coles AJ, Molyneux P, Compston DA, Barkhof F, Thompson AJ, McDonald WI, Miller DH. Secondary progressive multiple sclerosis: the relationship between short-term MRI activity and clinical features. Brain 1998;121:225-31.
59. Nijeholt GJ, van Walderveen MA, Castelijns JA, van Waesberghe JH, Polman C, Scheltens P, Rosier PF, Jongen PJ, Barkhof F. Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms. Brain 1998;121:687-97.
60. Enzinger C, Ropele S, Strasser-Fuchs S, Kapeller P, Schmidt H, Poltrum B, Schmidt R, Hartung HP, Fazekas F. Lower levels of N-acetylaspartate in multiple sclerosis patients with the apolipoprotein E epsilon4 allele. Arch Neurol 2003;60:65-70.
61. Oksenberg JR, Barcellos LF. The complex genetic aetiology of multiple sclerosis. J Neurovirol 2000;6(suppl 2):S10-14.
62. Strous SE, Sneller M, Lenardo MJ, Puck JM, Strober W. An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome. Ann Intern Med. 1999;130:591-601.
63. Martin DA, Zheng L, Siegel RM, Huang B, Fisher GH, Wang J, Jackson CE, Puck JM, Dale J, Straus SE, Peter ME, Krammer PH, Fesik S, Lenardo MI. Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type 1a. Proc Natl Acad Sci USA 1999;96:4552-7.
64. Droppa J, Vaishnaw AK, Sullivan KE, Chu JL, Elkon KB. Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity. N Engl J Med 1996;335:1643-9.
65. Wang J, Zheng L, Lobito A, Chan FK, Dale J, Sneller M, Yao X, Puck JM, Straus SE, Lenardo MI. Inherited human caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell 1999;98:47-58.
66. Lenardo M, Chan KM, Hornung F, McFarland H, Siegel R, Wang J, Zheng L. Mature T lymphocyte apoptosis - immune regulation in a dynamic and unpredictable antigenic environment. Annu Rev Immunol 1999;17:221-53.
67. Salvador JM, Hollander MC, Nguyen AT, Kopp JB, Barisoni L, Moore JK, Ashwell JD, Fornace AJ Jr. Mice lacking the p53-effector gene Gadd45a develop a Lupus-like syndrome. Immunity 2002;16:499-508.
68. Balomenos D, Martin-Caballero J, Garcia MI, Prieto I, Flores JM, Serrano M, Martinez-A C. The cell cycle inhibitor p21 controls T-cell proliferation and sex-linked lupus development. Nat Med 2000;6:171-6.
69. Yan J, Mamula MJ. Autoreactive T cells revealed in the normal repertoire: escape from negative selection and peripheral tolerance. J Immunol 2002;168:3188-94.
70. Zhang J, Markovic-Plese S, Lacet B, Raus J, Weiner HL, Hafler DA. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J Exp Med 1994;179:973-84.
71. Nguyen LT, Ramanathan M, Weinstock-Guttman B, Baier M, Brownscheidle C, Jacobs LD. Sex differences in vitro pro-inflammatory cytokine production from peripheral blood of multiple sclerosis patients. J Neurol Sci 2003;209:93-9.
72. Balomenos D, Martinez AC. Cell-cycle regulation in immunity, tolerance and autoimmunity. Immunol Today 2000;21:551-5.
73. Maas K, Chan S, Parker J, Slater A, Moore J, Olsen N, Aune TM. Cutting edge: molecular portrait of human autoimmune disease. J Immunol 2002;169:5-9.
74. Martin R, Sturzebecher CS, McFarland HF. Immunotherapy of multiple sclerosis: where are we? Where should we go? Nat Immunol 2001;2:785-8.
75. Schena M, Shalon D, Davis RW, Brown PO. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995;270:467-70.
76. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998;4:844-7.
77. MacBeath G, Schreiber SL. Printing proteins as microarrays for high-throughput function determination. Science 2000;289:1760-3.
78. Ziauddin J, Sabatini DM. Microarrays of cells expressing defined cDNAs. Nature 2001;411:107-10.
79. Mousses S, Kallioniemi A, Kauraniemi P, Elkahloun A, Kallioniemi OP. Clinical and functional target validation using tissue and cell microarrays. Curr Opin Chem Biol 2002;6:97-101.
80. Voorhoeve PM, Agami R. Knockdown stands up. Trends Biotechnol 2003;21:2-4.
81. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, Powell JI, Yang L, Marti GE, Moore T, Hudson J Jr, Lu L, Lewis DB, Tibshirani R, Sherlock G, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Warnke R, Levy R, Wilson W, Greveer MR, Byrd JC, Botstein D, Brown PO, Staudt LM. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling Nature 2000;403:503-11.
82. Hedenfalk I, Duggan D, Chen Y, Radmacher M, Bittner M, Simon R, Meltzer P, Gusterson B, Esteller M, Kallioniemi OP, Wilfond B, Borg A, Trent J. Gene-expression profiles in hereditary breast cancer. N Engl J Med 2001;344:539-48.
83. Davis RE, Brown KD, Siebenlist U, Staudt LM. Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells. J Exp Med 2001;194:1861-74.
84. van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MI, Parrish M, Atsma D, Witteveen A, Glas A, Delahaye L, van der Velde T, Bartelink H, Rodenhuis S, Rutgers ET, Friend SH, Bernards R. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002;347:1999-2009.
85. Knight J. Cancer comes under scrutiny in fresh genomic initiative. Nature 2001;410:855.
86. Dalton R. Phoenix rises to genomic challenge. Nature 2002;417:107.
87. Stephenson J. Human genome studies expected to revolutionize cancer classification. JAMA 1999;282:927-8.
88. Vastag B. Gene chips inch toward the clinic. JAMA 2003;289:155-9.
89. Whitney AR, Diehn M, Popper SJ, Alizadeh AA, Boldrick JC, Relman DA, Brown PO. Individuality and variation in gene expression patterns in human blood. Proc Natl Acad Sci USA 2003;100:1896-901.
90. Ramanathan M, Weinstock-Guttman B, Nguyen LT, Badgett D, Miller C, Patrick K, Brownscheidle C, Jacobs L. In vivo gene expression revealed by cDNA arrays: the pattern in relapsing-remitting multiple sclerosis patients compared with normal subjects. J Neuroimmunol 2001;116:213-19.
91. Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 2000;47:707-17.
92. Lassmann H, Bruck W, Lucchinetti C. Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy. Trends Mol Med 2001;7:115-21.
93. Bielekova B, Kadom N, McFarland H, Martin R. Immunoreactivity to different autoantingens in MS patients influences their disease phenotype. International Society of Neuroimmunology - Sixth International Congress. J Neuroimmunol 2001;118/1:A242.
94. Bielekova B, Kadom N, Frank J, McFarland H, Martin R. Immunoreactivity to myelin epitopes differ between MS patients subgrouped based on MRI and clinical characteristics of the disease. In: Proceedings of 2002 AAN Annual Meeting, S33.001, Denver, Colorado, USA.
95. Miller LD, Long PM, Wong L, Mukherjee S, McShane LM, Liu ET. Optimal gene expression analysis by microarrays. Cancer Cell 2002;2:353-61.
96. Lai E, Bowman C, Bansal A, Hughes A, Mosteller M, Roses AD. Medical applications of haplotype-based SNP maps: learning to walk before we run. Nat Genet 2002;32:353.